This pathway is focused on the management of non-visible haematuria. It has been published in response to feedback that has suggested that some GPs may be unsure when it comes to the management of non-visible haematuria, which may potentially be leading to patients being referred unnecessarily through the 2 week wait pathway.
The Pathway has also been published to coincide with the launch of the new GP Care Community Urology Service at the Aspen Centre in Gloucester. This service provides a one stop assessment and diagnostic service for common urological conditions, including non-visible haematuria, providing important additional capacity within the county in addition to pre-existing commissioned services (Care UK, Gloucestershire Hospitals NHS Foundation Trust, Tetbury Hospital Trust, and Winfield Hospital).
Please click the relevant flowchart box to be taken directly to textual information.
For patients who have had a urological cause excluded, or have not met the referral criteria for a urological assessment, a nephrology referral should be considered. The need for a nephrology referral in this situation depends on factors other than simply the presence of haematuria. See NICE chronic kidney disease guidelines for further information.
Patients not meeting criteria for referral to urology or nephrology, or who have had negative urological or nephrological investigations, need long term monitoring due to the uncertainty of the underlying diagnosis.
Patients should be monitored for the development of:
Please see the Patient & Carer Information & Leaflets section.
Please see the National and NICE Guidance section.
Significant Variations for this Pathway
There are no significant variations from the national standards
Please see the GP Education section.
Dr Jon Rees
GPwSI in Urology
Shire Health Ltd
|Dr Malcolm Gerald||GP||Gloucestershire Clinical Commissioning Groupemail@example.com|
|Richard Thorn||Commissioning Manager, Planned Care||Gloucestershire Clinical Commissioning Groupfirstname.lastname@example.org|
Following concern regarding unnecessary referrals through the 2 week wait pathway and to accompany the launch of the new GP Care Community Urology Service.